By representing equities in multi sectors we offset investor risk no different than the approach we would take in our own investment portfolios. Brisco acts on a referral basis, all clients are scrutinized through layers of due diligence by capital market members in order to protect the investment community we represent. The system is not perfect by any means but every precaution is needed to avoid investment losses in today’s volatile market.
Crystal Exploration is a Canadian based mineral exploration company focused on the discovery, financing and development of diamond assets.
Graphite One Resources is exploring with the intent to develop the Graphite Creek Deposit, the USA’s only advanced stage large-scale, large flake graphite deposit.
Aequus Pharmaceuticals Inc. is a Vancouver-based company, focused on enhancing delivery methods for approved drugs and select consumer products.
Bearing Lithium is a mineral exploration and development company, focused primarily on lithium.
Cobalt Power Group is a publicly traded Canadian cobalt exploration and development company listed on the TSX Venture Exchange (CPO.V) and the US Pink Sheets (CBBWF).
CVR Medical Corp. is a company that is involved in an equal parts joint venture with CVR Global Inc. (the “Joint Venture”).
Hemisphere Energy is focused on adding value per share by increasing production, reserves and cash flow through identifying and developing low to medium risk drilling opportunities and executing on strategic acquisitions and farm-ins.
InPlay Oil Corp. is a growth-oriented light oil development and production company based in Calgary, Alberta.
Nevada Zinc is a Canadian-based mineral exploration company primarily focused on the acquisition, exploration and development of mineral properties in Nevada and Yukon.
West Red Lake Gold Mines Inc. is a Toronto based company focused on gold exploration and development in the prolific Red Lake Gold District of Northwestern Ontario, Canada.
Immunovaccine is a clinical-stage vaccine development company focused on advancing its patented DepoVax™ vaccine adjuvanting platform and product candidates for cancer therapy and infectious diseases.
Trenchant Capital is an investment issuer that has formed a strategic alliance with one of the largest private equity firms in Canada.